Skip to content
Screener

OrthoPediatrics KIDS Investing Cash Flow

Investing Cash Flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
-$1.11B+93.9%
Stryker logo
StrykerSYK
-$639M-514%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$12.65M-78.2%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
-$190.8M+86.2%
Medtronic logo
MedtronicMDT
-$917M-87.1%
Treace Medical Concepts, Inc. logo
Treace Medical Concepts, Inc.TMCI
-$7.82M-313%

Other financials

Income statement

See full
Revenue$70.5M+15.4%
Gross profit$52.4M+19.0%
Operating income-$4.1M+61.8%
Net income-$7.2M-0.7%
EPS (diluted)-$0.300.0%

Balance sheet

See full
Cash & equivalents$19.1M-59.1%
Total debt$4.6M+234%
Total equity$343.6M-3.3%
Total assets$511.4M+1.5%

Cash flow

See full
Operating cash flow-$3.3M+20.9%
CapEx$4.0M+17.4%
Free cash flow-$3.1M+77.6%

Valuation

See full
Market cap$594.52M+26.1%
Enterprise value$580.02M+36.0%
P/S2.4×+0.2×

Profitability

See full
Gross margin73.7%+2.1pp
Operating margin-11.9%-3.2pp
Net margin-15.7%-2.3pp
FCF margin-12.9%-4.3pp

Returns & leverage

See full
Return on equity-11.4%-0.1pp
Debt / equity0.0×
Current ratio4.8×-1.9×

Where this comes from

Reported directly by OrthoPediatrics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: OrthoPediatrics’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 1:56 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001425450-26-000070
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Investment in private companies and purchases of licenses(330)(1,540)
Loss on investment in private companies284
Purchases of property and equipment(5,805)(7,672)
Net cash provided by (used in) investing activities1,213(9,532)
FINANCING ACTIVITIES
Proceeds from issuance of debt25,000
Payment on debt issuance costs(289)
Payments on mortgage notes(85)(78)

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is OrthoPediatrics's investing cash flow?
OrthoPediatrics (KIDS) reported investing cash flow of $5M in Q2 2026.
How has OrthoPediatrics's investing cash flow changed year-over-year?
OrthoPediatrics's investing cash flow increased by 241.0% year-over-year, from -$3.55M to $5M.
What is the long-term trend for OrthoPediatrics's investing cash flow?
Over 2 years (2022 to 2025), OrthoPediatrics's investing cash flow has grown at a -38.0% compound annual growth rate (CAGR), from -$113.37M to -$43.63M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about OrthoPediatrics's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude